C12N 2770/30034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/30034 (Use of virus or viral component as vaccine) appears on 8 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 17
- Assignees
- 18
- Inventors
- 43
- Latest grant
- 24 Nov 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 0 | 2 |
| 2018 | 2 | 0 |
| 2019 | 3 | 3 |
| 2020 | 2 | 2 |
By publication year.
Recent patents
- DNA constructs for manufacturing bio-therapuetic polypeptides for use in animal vaccines and therapeutics24 Nov 2020US 10,844,382 B2MicroSynbiotiX, Ltd.
- Feed additive composition for immunoprotection of fish against infectious viral species6 Oct 2020US 10,792,354 B2Allotropic Tech, LLC
- Algal based edible vaccines19 Nov 2019US 10,480,002 B2Transalgae Israel Ltd.
- rDNA NTS-based gene multiple insertion cassette set and GRAS-grade recombinant yeast strain29 Oct 2019US 10,457,949 B2Chung-Ang University Industry-Academy Cooperation Foundation
- Methods of producing viruses22 Oct 2019US 10,450,544 B2Benchmark Animal Health Limited
- Non-cross-linked acellular pertussis antigens for use in combination vaccines7 May 2020US 2020/0138927 A1Glaxosmithkline Biologicals SA
- Algal based edible vaccines27 Feb 2020US 2020/0063152 A1Transalgae Israel Ltd.
- Oral vaccine composition for immunoprotection of fish against infectious viral species4 Jul 2019US 2019/0201518 A1Allotropic Tech, LLC
- Dna constructs for manufacturing bio-therapuetic polypeptides for use in animal vaccines and therapeutics16 May 2019US 2019/0142924 A1MicroSynbiotiX, Ltd.
- Methods of producing viruses7 Feb 2019US 2019/0040354 A1Benchmark Animal Health Limited
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.